United Therapeutics Corporation (UT) sought to design and develop the first full service Ex Vivo Lung Perfusion (EVLP) Center in the United States. Time to market was critical for the delivery of the building for initiating US clinical trials.
Facility Logix led UT’s team in the development of the 28,550 gsf lung research and development facility. The entire project was designed and built in 10 months. The work included renovation of an existing class “C” medical office building and a 12,800 gsf addition with six (6) operating room suites to support lung research and development. In addition to traditional Owner’s Representation Services, Facility Logix managed the procurement of all medical and laboratory equipment and managed the licensure of the facility through the Maryland Department of the Environment.
The Business Development Board of Palm Beach County (BDB) retained Facility Logix to conduct an analysis of the county’s life science industry.
Facility Logix worked with a local real estate provider to detail the property’s attributes and to evaluate the potential market for a buyer of the building for its highest and best use as a fill-finish site.
Johns Hopkins FastForward business accelerator program sought to understand Baltimore City, regional and statewide lab space market dynamics to guide the design of its planned 1812 Ashland incubator
Facility Logix worked with IBT and its real estate representation team to evaluate options for its new facility. We are currently overseeing the design, engineering and build-out of the new facility that will open in September 2016.